Vardenafil in Erectile Dysfunction: The Evidence of Its Therapeutic Value
Keyword(s):
Erectile dysfunction (ED) is a condition that affects approximately 18 million American men. Phosphodiesterase-5 inhibitors (PDE5i's) have revolutionized the treatment of erectile dysfunction by providing the first highly-effective oral medication. Vardenafil is one of 3 PDE5i's commercially available for the treatment of ED in the United States. It has demonstrated therapeutic efficacy in the management of uncomplicated ED as well as more refractory cases associated with diabetes and surgery for prostate cancer. The physiology, pharmacokinetics, pharmacodynamics, and primary literature evaluating vardenafil are reviewed.
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
1994 ◽
Vol 86
(23)
◽
pp. 1790-1792
◽
Keyword(s):